Google and I have some good karma this year it seems. Every time I do a Google story it instantly gets good ratings. In August my story “Is Gmail going Offline?” was picked up by over 7,523 news sites across the world. It also figured on prominent sites like Techcrunch, Wired, Zdnet etc. Google and my good karma continued in my early November story on Open Social, (Open Social, a Masterstroke by Google.) It not just figured in the top news on Google news homepage for a few days but also invited some really inspiring comments like this one below:

Daniel DeConinck to puneet Nov 4

Hello Puneet,

You are an excellent technology journalist. You grasp the fundamental essence of a story and communicate it in a clear efficient manner.

When I saw you were from india I was surprised. I know that about 10 or 20% of executives in silicon valley are indian and that indians excel in IT, however the Indian journalism that I have read in the past has looked like it was written by high school students.

Very refreshing to see the highest calibre of journalism following from India.

Please tell me honestly, do I sound like an ignorant racist American ?


P.S. - I line in Toronto Canada. ( surrounded by Indians )



Sincerely Daniel DeConinck,
PixelSmart Tel 416-239-3333 or 800-884-1734 www.PixelSmart.com

Now that surely sounds nice. Just for information the comments I receive can be best categorized into informative, appreciative and (politely termed) constructive.

If this year was the phase of good karma between Google and me I wonder what karma it was when I wrote the story ‘Shame on you Google” a year and a half ago when Google sold itself to the Chinese.

Larry’s Column

Recent advances in Small Business Executive Medicine research have discovered a serious, possibly fatal, disease that affects business executives and managers. It arrives here in Northwest Indiana somewhere between the first frost and the first snowfall. Maybe the change in temperature causes a change in the immune system that brings on the symptoms as the end of the year approaches however it may not be weather related since the symptoms show up where frost and snow rarely appear.

Read more

Aptuit, Inc. today announced that it has completed the acquisition of the Chemical and Pharmaceutical Development (CPD) business of Evotec, which integrates an active pharmaceutical ingredient (API) facility in Oxford, England and a well-established and recently-expanded parenteral (injectable vials) fill/finish facility in Glasgow, Scotland Read more